Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

The New England Journal of Medicine
Klaus F RabeAriel Teper

Abstract

Dupilumab is a fully human anti-interleukin-4 receptor α monoclonal antibody that blocks both interleukin-4 and interleukin-13 signaling. Its effectiveness in reducing oral glucocorticoid use in patients with severe asthma while maintaining asthma control is unknown. We randomly assigned 210 patients with oral glucocorticoid-treated asthma to receive add-on dupilumab (at a dose of 300 mg) or placebo every 2 weeks for 24 weeks. After a glucocorticoid dose-adjustment period before randomization, glucocorticoid doses were adjusted in a downward trend from week 4 to week 20 and then maintained at a stable dose for 4 weeks. The primary end point was the percentage reduction in the glucocorticoid dose at week 24. Key secondary end points were the proportion of patients at week 24 with a reduction of at least 50% in the glucocorticoid dose and the proportion of patients with a reduction to a glucocorticoid dose of less than 5 mg per day. Severe exacerbation rates and the forced expiratory volume in 1 second (FEV1) before bronchodilator use were also assessed. The percentage change in the glucocorticoid dose was -70.1% in the dupilumab group, as compared with -41.9% in the placebo group (P<0.001); 80% versus 50% of the patients had a d...Continue Reading

References

Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine·J L HankinsonK B Fedan
Jun 12, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Kathleen Ververeli, Bradley Chipps
Apr 13, 2005·Respiratory Medicine·Elizabeth F JuniperElisabeth Ståhl
Sep 29, 2007·The Journal of Allergy and Clinical Immunology·Elena GolevaDonald Y M Leung
Oct 2, 2007·Journal of Leukocyte Biology·Steven R BarthelDeane F Mosher
Aug 8, 2008·Annals of the Rheumatic Diseases·D HuscherF Buttgereit
Nov 8, 2008·American Journal of Respiratory and Critical Care Medicine·Paul M O'ByrneUNKNOWN START Investigators Group
Mar 7, 2009·The New England Journal of Medicine·Pranabashis HaldarIan D Pavord
Mar 7, 2009·The New England Journal of Medicine·Parameswaran NairPaul M O'Byrne
Sep 3, 2011·American Journal of Respiratory and Critical Care Medicine·Raed A DweikUNKNOWN American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Jan 22, 2013·Nature Reviews. Drug Discovery·Patricia C Fulkerson, Marc E Rothenberg
May 22, 2013·The New England Journal of Medicine·Sally WenzelGianluca Pirozzi
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Lynn E MacdonaldAndrew J Murphy
Sep 10, 2014·The New England Journal of Medicine·Elisabeth H BelUNKNOWN SIRIUS Investigators
Sep 12, 2015·The European Respiratory Journal·Dominick E ShawUNKNOWN U-BIOPRED Study Group
Oct 4, 2016·The New England Journal of Medicine·Eric L SimpsonUNKNOWN SOLO 1 and SOLO 2 Investigators
Dec 31, 2016·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D RobinsonP Nair
May 23, 2017·The New England Journal of Medicine·Parameswaran NairUNKNOWN ZONDA Trial Investigators
May 22, 2018·The New England Journal of Medicine·Mario CastroAriel Teper

❮ Previous
Next ❯

Citations

May 22, 2018·The New England Journal of Medicine·Jeffrey M Drazen, David Harrington
May 22, 2018·The New England Journal of Medicine·Mario CastroAriel Teper
Nov 22, 2018·Current Opinion in Pulmonary Medicine·Ian D Pavord
Dec 5, 2018·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Khalid Al EfraijJ Mark FitzGerald
Dec 5, 2018·Expert Opinion on Investigational Drugs·Giancarlo MaroneGilda Varricchi
Nov 18, 2018·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Jocelyne JustFlore Amat
Nov 9, 2018·Current Opinion in Allergy and Clinical Immunology·Enrico HefflerGiorgio W Canonica
Jan 12, 2019·Expert Opinion on Drug Metabolism & Toxicology·Diego BagnascoGiorgio Walter Canonica
Dec 19, 2018·American Journal of Respiratory and Critical Care Medicine·J Michael RamsahaiPeter A B Wark
Dec 12, 2018·American Journal of Respiratory and Critical Care Medicine·Mary Clare McGregorMario Castro
Feb 15, 2019·Vaccines·John Foerster, Aleksandra Molęda
Jan 17, 2019·Current Opinion in Allergy and Clinical Immunology·Elise M SlobMariëlle W Pijnenburg
Feb 15, 2019·The European Respiratory Journal·Parameswaran Nair, Paul M O'Byrne
Nov 18, 2018·The European Respiratory Journal·William W BusseGene Colice
Mar 13, 2019·JAMA : the Journal of the American Medical Association
Feb 15, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Claire N McBrien, Andrew Menzies-Gow
Feb 21, 2019·The Journal of Infectious Diseases·Fernando P PolackAdnan Custovic
May 3, 2019·Medicine·Guoming ChenLi Wei
Mar 10, 2019·The British Journal of Dermatology·B AkinladeA Wollenberg
May 21, 2019·Expert Opinion on Drug Metabolism & Toxicology·Luigino CalzettaPaola Rogliani
Jun 21, 2019·Immunotherapy·Alice Grey, Constance H Katelaris
May 3, 2019·The European Respiratory Journal·Paul O'ByrnePeter Lange
May 31, 2019·Current Opinion in Allergy and Clinical Immunology·Jorien van der SchaftDeepak M W Balak
Jun 7, 2019·Current Opinion in Allergy and Clinical Immunology·Sara M Assaf, Nicola A Hanania
Jul 4, 2019·Allergy·P Jane McDowell, Liam G Heaney
Jul 30, 2019·European Journal of Immunology·Lorenzo CosmiFrancesco Annunziato
Aug 8, 2019·Expert Review of Clinical Immunology·Enrico HefflerGiorgio Walter Canonica
Jun 21, 2019·International Journal of Molecular Sciences·Mayumi SaekiOsamu Kaminuma
Sep 8, 2019·Archives of Dermatological Research·Julie K NguyenJared Jagdeo
Sep 5, 2019·Journal of Clinical Medicine·Agamemnon BakakosPetros Bakakos
Oct 1, 2019·Annals of Internal Medicine·Melissa B King-Biggs
Sep 11, 2019·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Hani Harb, Talal A Chatila
Oct 17, 2019·Revista da Associação Médica Brasileira·Cíntia BassaniLuciana Kase Tanno
Sep 25, 2019·Expert Opinion on Investigational Drugs·Giancarlo MaroneGilda Varricchi
Nov 13, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Li Ping ChungMark Hew
Nov 16, 2019·Drugs·Emma D Deeks
Sep 14, 2019·The European Respiratory Journal·Richard J MartinHelen K Reddel
May 31, 2019·Expert Opinion on Biological Therapy·Daniel EnnisChristian Pagnoux

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.